Related Experiment Video
Updated: May 13, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Referral patterns for patients with high-risk thyroid cancer
Megan R Haymart1, Mousumi Banerjee, Di Yang
1Department of Medicine, University of Michigan, Ann Arbor, MI 48109-2800, USA. meganhay@umich.edu
Summary
Many endocrinologists manage thyroid cancer, but referral patterns for high-risk patients are unclear. Understanding these patterns is key to improving specialized cancer care and patient outcomes.
Area of Science:
- Oncology
- Endocrinology
Background:
- Referral patterns for specialized cancer care are not well-documented.
- Understanding referral needs for high-risk, well-differentiated thyroid cancer patients is crucial for improving patient care.
Purpose of the Study:
- To investigate referral patterns among endocrinologists for high-risk thyroid cancer patients.
- To identify the primary reasons for referring these patients to specialized facilities.
Main Methods:
- A survey was distributed to 370 endocrinologists managing thyroid cancer.
- Respondents analyzed clinical vignettes to determine referral reasons for high-risk patients.
- Multivariable analysis was performed, controlling for physician and hospital characteristics.
Main Results:
- 32% of endocrinologists reported never referring thyroid cancer patients.
- For those who do refer, clinical trial access (44%) was the leading reason, followed by high-dose radioactive iodine (RAI) therapy (33%).
- Endocrinologists dedicating more practice time to thyroid cancer were less likely to refer patients (P = .003).
Conclusions:
- Most endocrinologists refer high-risk thyroid cancer patients for specialized care.
- Identifying referral patterns and needs is essential for addressing referral discrepancies and improving the referral process.
More Related Videos
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...